Literature DB >> 6306096

Tests for coxsackie B virus-specific IgM.

J R Pattison.   

Abstract

Mesh:

Substances:

Year:  1983        PMID: 6306096      PMCID: PMC2134265          DOI: 10.1017/s0022172400028965

Source DB:  PubMed          Journal:  J Hyg (Lond)        ISSN: 0022-1724


× No keyword cloud information.
  9 in total

1.  Gel double diffusion studies with group B and group A, type 9 Coxsackie viruses. II. Serologic diagnosis of Coxsackie virus infections by the gel double diffusion technique.

Authors:  N J SCHMIDT; E H LENNETTE
Journal:  J Immunol       Date:  1962-07       Impact factor: 5.422

2.  Counterimmunoelectrophoresis test for immunoglobulin M antibodies to group B coxsackievirus.

Authors:  T E Minor; P B Helstrom; D B Nelson; D J D'Alessio
Journal:  J Clin Microbiol       Date:  1979-04       Impact factor: 5.948

3.  Immunological studies of the group B coxsackieviruses by the sandwich enzyme-linked immunosorbent assay (ELISA) and immunoprecipitation.

Authors:  M G Katze; R L Crowell
Journal:  J Gen Virol       Date:  1980-10       Impact factor: 3.891

4.  Coxsackie-B-virus-specific IgM responses in patients with cardiac and other diseases.

Authors:  M M El-Hagrassy; J E Banatvala; D J Coltart
Journal:  Lancet       Date:  1980-11-29       Impact factor: 79.321

5.  Indirect enzyme-linked immunosorbent assay (ELISA) for the detection of Coxsackievirus group B antibodies.

Authors:  M G Katze; R L Crowell
Journal:  J Gen Virol       Date:  1980-05       Impact factor: 3.891

6.  Association of group B coxsackie viruses with cases of pericarditis, myocarditis, or pleurodynia by demonstration of immunoglobulin M antibody.

Authors:  N J Schmidt; R L Magoffin; E H Lennette
Journal:  Infect Immun       Date:  1973-09       Impact factor: 3.441

7.  Detection of enterovirus specific IgG and IgM antibodies in humans by an indirect solid phase radioimmunoassay.

Authors:  R Dörries; V ter Meulen
Journal:  Med Microbiol Immunol       Date:  1980       Impact factor: 3.402

8.  Specificity of IgM antibodies in acute human coxsackievirus B infections, analysed by indirect solid phase enzyme immunoassay and immunoblot technique.

Authors:  R Dörries; V ter Meulen
Journal:  J Gen Virol       Date:  1983-01       Impact factor: 3.891

9.  Antibody capture radioimmunoassay (MACRIA) for coxsackievirus B4 and B5-specific IgM.

Authors:  P Morgan-Capner; C McSorley
Journal:  J Hyg (Lond)       Date:  1983-06
  9 in total
  6 in total

1.  Subclass restriction of human enterovirus antibodies.

Authors:  E G Torfason; C B Reimer; H L Keyserling
Journal:  J Clin Microbiol       Date:  1987-08       Impact factor: 5.948

2.  Cross-reactions of immunoglobulin M and G antibodies with enterovirus-specific viral structural proteins.

Authors:  F Reigel; F Burkhardt; U Schilt
Journal:  J Hyg (Lond)       Date:  1985-10

Review 3.  Enteroviruses as agents of emerging infectious diseases.

Authors:  G Palacios; M S Oberste
Journal:  J Neurovirol       Date:  2005-10       Impact factor: 2.643

4.  Comparison of serodiagnosis of group B coxsackievirus infections by an immunoglobulin M capture enzyme immunoassay versus microneutralization.

Authors:  D Chan; G W Hammond
Journal:  J Clin Microbiol       Date:  1985-05       Impact factor: 5.948

5.  The Swedish childhood diabetes study III: IgM against coxsackie B viruses in newly diagnosed type 1 (insulin-dependent) diabetic children--no evidence of increased antibody frequency.

Authors:  T Tuvemo; G Dahlquist; G Frisk; L Blom; G Friman; M Landin-Olsson; H Diderholm
Journal:  Diabetologia       Date:  1989-10       Impact factor: 10.122

6.  Multiplexed High-Throughput Serological Assay for Human Enteroviruses.

Authors:  Niila V V Saarinen; Jussi Lehtonen; Riitta Veijola; Johanna Lempainen; Mikael Knip; Heikki Hyöty; Olli H Laitinen; Vesa P Hytönen
Journal:  Microorganisms       Date:  2020-06-26
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.